Jeffrey Cohen analyst LADENBURG

Currently out of the existing stock ratings of Jeffrey Cohen, 27 are a BUY (87.1%), 4 are a HOLD (12.9%).

Jeffrey Cohen

Work Performance Price Targets & Ratings Chart

Analyst Jeffrey Cohen, currently employed at LADENBURG, carries an average stock price target met ratio of 60.74% that have a potential upside of 43.89% achieved within 271 days.

Jeffrey Cohen’s has documented 59 price targets and ratings displayed on 9 stocks. The coverage is on Healthcare, Consumer Defensive sectors.

Most recent stock forecast was given on LGCY, Legacy Education at 15-May-2026.

Wall Street Analyst Jeffrey Cohen

Analyst best performing recommendations are on CDXC (CHROMADEX CORP).
The best stock recommendation documented was for CDXC (CHROMADEX CORP) at 3/5/2025. The price target of $8.1 was fulfilled within 1 day with a profit of $0.45 (5.26%) receiving and performance score of 52.63.

Average potential price target upside

CDXC Chromadex Corp CELH Celsius Holdings CRY CryoLife ECOR Electrocore LLC HROW Harrow Health LGCY Legacy Education MTBC CareCloud SPNE SeaSpine Holdings Corp TRXC Asensus Surgical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Sep-2017

$8.1

$0.36 (4.65%)

$12

Buy Since 09-Mar-2022

$8

$0.26 (3.36%)

$8

Hold Since 03-Nov-2022

$2

$-5.74 (-74.16%)

$2.1

Show more analysts

Please expand the browser size to see the chart

Which stock is Jeffrey Cohen is most bullish on?

Potential upside of $4.85 has been obtained for LGCY (LEGACY EDUCATION)

What Year was the first public recommendation made by Jeffrey Cohen?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?